ExodusPoint Capital Management’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-93,804
| Closed | -$1.24M | – | 1765 |
|
2024
Q4 | $1.24M | Sell |
93,804
-11,672
| -11% | -$154K | 0.01% | 808 |
|
2024
Q3 | $1.18M | Buy |
105,476
+12,232
| +13% | +$137K | 0.01% | 867 |
|
2024
Q2 | $1M | Buy |
93,244
+15,668
| +20% | +$168K | 0.01% | 901 |
|
2024
Q1 | $1.16M | Buy |
77,576
+59,471
| +328% | +$886K | 0.01% | 791 |
|
2023
Q4 | $328K | Sell |
18,105
-9,017
| -33% | -$163K | ﹤0.01% | 1085 |
|
2023
Q3 | $470K | Buy |
27,122
+6,902
| +34% | +$120K | ﹤0.01% | 1223 |
|
2023
Q2 | $366K | Buy |
20,220
+5,242
| +35% | +$94.9K | ﹤0.01% | 1378 |
|
2023
Q1 | $398K | Sell |
14,978
-26,247
| -64% | -$697K | ﹤0.01% | 1304 |
|
2022
Q4 | $797K | Buy |
+41,225
| New | +$797K | 0.01% | 994 |
|
2021
Q3 | – | Sell |
-14,499
| Closed | -$422K | – | 2433 |
|
2021
Q2 | $422K | Buy |
+14,499
| New | +$422K | ﹤0.01% | 1473 |
|